Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Nabumetone Tablets, 500 mg, Second () Copley Pharmaceutical, ANDA 75-179 6/6/00 6/9/00 12/31/01 Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 S-01, S-02 9/24/01 4/9/03 Nabumetone Tablets, 500 mg & 750 mg, Teva USA ANDA 75-189 5/26/00 6/6/00 12/28/01 Nabumetone Tablets, 500 mg and 750 mg, (Tentatively approved 12/24/98) Teva USA ANDA 75-189 12/24/98 12/24/98 Nabumetone Tablets, 500 mg and 750 mg, Eon Labs Manufacturing ANDA 75-280 2/25/02 4/10/03 Nabumetone Tablets, 500 mg and 750 mg, August 6 Eon Labs Manufacturing ANDA 75-280 8/6/98 8/7/98 Nabumetone Tablets, 500 mg and 750 mg, Invamed ANDA 75-590 2/25/02 Nabumetone Tablets, 500 mg and 750 mg, 3/21/01 Invamed ANDA 75-590 3/21/01 3/30/01 Nabumetone Tablets, 500 mg and 750 mg, Ivax ANDA 76-009 NABUMETONE Tablet; 750MG NABUMETONE Copley 075280 NABUMETONE Tablet; 500MG NABUMETONE Eon 075280 NABUMETONE Tablet; 750MG NABUMETONE Eon 019583 NABUMETONE Tablet; 500MG RELAFEN GLAXOSMITHKLINE 019583 NABUMETONE Tablet; 750MG RELAFEN GLAXOSMITHKLINE 075590 NABUMETONE Tablet; 500MG NABUMETONE INVAMED 075590 NABUMETONE Tablet; 750MG NABUMETONE INVAMED 076009 NABUMETONE Tablet; 500MG NABUMETONE Ivax 076009 NABUMETONE Tablet; 750MG NABUMETONE Ivax 075189 NABUMETONE Tablet; 500MG NABUMETONE Teva 075189 NABUMETONE Tablet; 750MG NABUMETONE Teva | RELAFEN (nabumetone) Tablet, GlaxoSmithKline, Labeling Revision | Relafen (nabumetone) Tablets, GlaxoSmithKline, Labeling Revision Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem.com